Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, emerging retail healthcare providers, pharmaceutical companies and insurers, commercial clinical laboratories, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. In addition, the company offers risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.

Quest Diagnostics Incorporated

Telsey Advisory analyst Joe Feldman maintained a Hold rating on Dollar General today and set a price target of $140.00. According to TipRanks, Feld...

Telsey Advisory Keeps Their Hold Rating on Dollar General (DG)

The latest announcement is out from Quest Diagnostics ( ($DGX) ). At its May 20, 2026 annual meeting of stockholders, Quest Diagnostics shareholder...

Quest Diagnostics Shareholders Back Board, Pay and Auditor

China Dongxiang (Group) Co ( ($HK:3818) ) has shared an announcement. China Dongxiang (Group) Co., Ltd. has scheduled a board meeting for 24 June 2...

China Dongxiang Schedules Board Meeting to Approve Annual Results and Consider Dividend

Integrated Diagnostics Holdings ( ($GB:IDHC) ) has provided an update. Integrated Diagnostics Holdings reported that all resolutions at its 19 May ...

Integrated Diagnostics Wins Strong Shareholder Backing at 2026 AGM

The latest update is out from Digi Power X ( ($TSE:DGX) ). On May 8, 2026, Digi Power X Inc. announced it had increased its at-the-market equity of...

Digi Power X Expands ATM Program to Fund Growth

The latest update is out from Quest Diagnostics ( ($DGX) ). On May 6, 2026, Quest Diagnostics issued $500 million of 5.000% senior unsecured notes ...

Quest Diagnostics Issues $500 Million Senior Unsecured Notes

Digi Power X ($DGXX) announced a massive new partnership on Tuesday, May 5, 2026, to build a giant data center in Columbiana, Alabama. The firm rea...

Digi Power X Stock (DGXX) Skyrockets on $2.5 Billion Deal with Cerebras Systems

An update from Quest Diagnostics ( ($DGX) ) is now available. On April 27, 2026, Quest Diagnostics priced a $500 million public offering of 5.000% ...

Current Quarter	$2.81	Next Quarter	$2.8
Current Year	$10.72	Next Year	$11.56
QoQ Growth	-0.4%	YoY Growth	+7.8%
3Y EPS CAGR	+3.1%	Target Price	$223.00
Consensus	Buy	Upside	+15.4%

Current Quarter Rev	N/A	Next Quarter Rev	N/A
Revenue Growth	N/A	YoY Growth	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	DGX	$193.29	-0.98%	357.06K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	DGX	$193.29	-1.0%	357.06K
3
4
5
6

DGX

DGX

EPS Estimates Overview

EPS Historical Trend (5 Years)

Quarterly EPS Estimates

Revenue Analysis

Get Quest Diagnostics Incorporated Data in Excel

Get Quest Diagnostics Incorporated Data in Excel